Coeptis Therapeutics Statistics
Total Valuation
COEP has a market cap or net worth of $10.21 million. The enterprise value is $6.11 million.
| Market Cap | 10.21M |
| Enterprise Value | 6.11M |
Important Dates
The next estimated earnings date is Friday, August 9, 2024, before market open.
| Earnings Date | Aug 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
COEP has 37.12 million shares outstanding. The number of shares has increased by 76.98% in one year.
| Shares Outstanding | 37.12M |
| Shares Change (YoY) | +76.98% |
| Shares Change (QoQ) | +38.36% |
| Owned by Insiders (%) | 31.64% |
| Owned by Institutions (%) | 12.78% |
| Float | 21.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.34 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.56.
| Current Ratio | 1.60 |
| Quick Ratio | n/a |
| Debt / Equity | 0.56 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -57.93 |
Financial Efficiency
Return on equity (ROE) is -434.20% and return on invested capital (ROIC) is -263.36%.
| Return on Equity (ROE) | -434.20% |
| Return on Assets (ROA) | -205.20% |
| Return on Capital (ROIC) | -263.36% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.26M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.70% in the last 52 weeks. The beta is -0.93, so COEP's price volatility has been lower than the market average.
| Beta (5Y) | -0.93 |
| 52-Week Price Change | -83.70% |
| 50-Day Moving Average | 0.32 |
| 200-Day Moving Average | 0.66 |
| Relative Strength Index (RSI) | 42.31 |
| Average Volume (20 Days) | 258,937 |
Short Selling Information
The latest short interest is 314,655, so 0.85% of the outstanding shares have been sold short.
| Short Interest | 314,655 |
| Short Previous Month | 546,766 |
| Short % of Shares Out | 0.85% |
| Short % of Float | 1.45% |
| Short Ratio (days to cover) | 0.31 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.87M |
| Pretax Income | -16.31M |
| Net Income | -16.31M |
| EBITDA | -15.03M |
| EBIT | -16.03M |
| Earnings Per Share (EPS) | -$0.54 |
Balance Sheet
The company has $6.53 million in cash and $2.43 million in debt, giving a net cash position of $4.10 million or $0.11 per share.
| Cash & Cash Equivalents | 6.53M |
| Total Debt | 2.43M |
| Net Cash | 4.10M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | 4.36M |
| Book Value Per Share | 0.12 |
| Working Capital | 2.58M |
Cash Flow
| Operating Cash Flow | -7.46M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.46M |
| FCF Per Share | -$0.21 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COEP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -76.98% |
| Shareholder Yield | -76.98% |
| Earnings Yield | -159.78% |
| FCF Yield | -73.06% |
Analyst Forecast
The average price target for COEP is $3.00, which is 990.91% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.00 |
| Price Target Difference | 990.91% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -17.19% |
Stock Splits
The last stock split was on August 6, 2020. It was a reverse split with a ratio of 1:40000.
| Last Split Date | Aug 6, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:40000 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |